AzTrials
AzTrials

DiaphragmNCT07007923

Recruitment of the Diaphragm and Sternocleidomastoid Muscle During Loaded Inspiration on Varying Sitting Support in Healthy Adults

An observational study of Diaphragm, run by Hong Kong Metropolitan University at 1 site in Hong Kong.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This is a cross-sectional obsessional study. This study explores how different sitting conditions affect two important muscles-the diaphragm and the sternocleidomastoid (SCM)-work during breathing exercises. The diaphragm is the main muscle for breathing, while the SCM helps when taking deeper breaths. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Diaphragm
How many people
45 participants
Where
1 siteHong Kong
Study dates
19 Jun 2025to 20 Apr 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: aged 18-35 healthy young adults

Who may be able to join

  • aged 18-35 years - No recent thoracic surgery in the past 6 months
  • Absence in history of chronic respiratory illness
  • Able to breathe spontaneously
  • Conscious, able to follow instructions on the use of IMT device

Who cannot join

  • with known cardiovascular, pulmonary or musculoskeletal disorders that would limit their functional capacity (E.g. Asthma, COPD)
  • presence with respiratory symptoms over past 2 weeks
  • pregnancy
  • malignancy
  • presence of neurological disorders (e.g. ALS, stroke)
  • PCS/ MCS in SF-12 scores below 50
  • Findings in spirometry suggesting presence of obstructive or restrictive disorders

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Yi On Mak, Bachelor of Physiotherapy contact

+85292328865

s1314212@live.hkmu.edu.hk

Hong Kong1 site
  • Hong Kong Metropolitan University Jockey Club Institute of Healthcare

    Hong Kong

    William Wai Nam Tsang, wntsang@hkmu.edu.hk

Other trials in Hong Kong

About this study

This is a cross-sectional obsessional study.

This study explores how different sitting conditions affect two important muscles-the diaphragm and the sternocleidomastoid (SCM)-work during breathing exercises. The diaphragm is the main muscle for breathing, while the SCM helps when taking deeper breaths. Understanding how these muscles interact while sitting under various conditions can help improve breathing training techniques.

Read more

The study's objectives are (1) to investigate the relationship between diaphragm thickness fraction with 4 different sitting conditions during loaded inspiration among healthy adults and (2) To investigate the relationship between SCM activity with 4 different sitting conditions during loaded inspiration among healthy adults.

This research will conduct healthy adults, who will be instructed to breathe against resistance provided by the IMT while sitting on four different conditions: a regular chair, a soft pad with feet on the ground, a soft pad with feet on two additional soft pads, and a single soft pad with both feet on one pad. By using ultrasound to measure how thick the diaphragm gets and surface electromyography (sEMG) to track SCM activity, the data will be gathered on how these muscles function under different conditions.

The goal is to find out if sitting on unstable surfaces, like soft pads, can enhance diaphragm use compared to a stable chair. These surfaces may change how effectively the diaphragm and SCM work together. This research could lead to better recommendations for inspiratory muscle training (IMT), which helps strengthen these muscles, especially for people with breathing difficulties.

By identifying how posture influences muscle recruitment during breathing exercises, hoping to contribute valuable insights that can improve rehabilitation programs for individuals with respiratory conditions.

Read the detailed description

Participant information sheets and consent form will be given and explained to participants prior to experiment. To ensure measurement consistency, one standardized assessor will be employed. Demographic data, including age, sex, exercise habit, and smoking history will be recorded. Health-related quality of life will be quantified by SF-12. Participants who score below 50 in PCS or MCS will be excluded from our study.

All eligible participants will undertake a standard spirometry test to obtain forced vital capacity (FVC), forced expiratory volume in one second (FEV1). Spirometry test will be performed 3 times, in accordance with guidelines recommended by the American Thoracic Society. Participants with findings of obstructive or restrictive disorders will be excluded. MIP will be obtained by a threshold device (S1breathe K5) under standard instruction. Before measuring MIP, specific instructions guiding participants to focus on diaphragm breathing will be instructed (one hand positioned on the subcostal region and allow air to go to the lower part of the chest where your hand is placed) to allow participants aware of the use of diaphragm during trials, therefore they can subconsciously deploy the technique in the subsequent trials. Participants will be allowed to perform 3 times (with nose-clip applied), with the best MIP will be recorded. The thickness of right diaphragm and SCM activity at maximum inspiration, maximum expiration, end-tidal inspiration, end-tidal expiration, and MIP were measured by ultrasonography and sEMG respectively.

Participants will then be instructed to perform IMT in different conditions in a randomized order, completing 4 sets 15 breaths, with a rest period of 5 mins between sets. 50% MIP will be calibrated at the POWERbreathe device with respect to each participant prior IMT. During each inspiratory pressure-targeted breath, simultaneous sEMG recording on the right SCM and ultrasonography of right hemi-diaphragm will be conducted. Participants's subjective exertion level will be recorded by Borg's Rate of Perceived Exertion Scale at the end of each set of recordings.

The POWERbreathe device requires 5 breaths to meet the targeted load. Following the manufacturer's instructions, participants will be instructed to perform with a sharp inspiration lasting 1-2s at each breath for reaching the required load. Each participant will be requested to complete 15 breaths, but only the data from 6th to 15th breaths will be included for analysis. The whole duration will take around 90 minutes. Password code will be used to guarantee anonymity and confidentiality for the data obtained.

Conditions
Diaphragm
Keywords
Diaphragmatic thickening fraction, Sternocleidomastoid muscles, inspiratory pressure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diaphragmatic thickening fraction

    Diaphragmatic thickening fraction is determined by "(thickness of the diaphragm at end inspiratory - thickness at end expiratory)/thickness at end expiratory". Diaphragmatic thickness will be measured by ultrasonography.

    Measured: Through study completion, an average of 1 year

Secondary outcomes (2)
  1. Muscle activation of the sternocleidomastoid muscle

    Surface electromyography will be used to measure accessory inspiratory muscle (sternocleidomastoid muscles) activity during each inspiratory muscle training intensity.

    Measured: Through study completion, an average of 1 year

  2. Borg's scale

    The Borg scale is widely used for measuring perceived exertion during physical activity. It can gauge how hard individuals are exerting while taking into account the individual's heart rate, breathing effort, and fatigue level. Participant's subjective experience would also gauge the score of the scale. The Borg RPE scale would be used to measure exertion during exercise as it has a high correlation with physiological measurements. It is quantified from 0 to 10, where 0 represents no symptoms, and 10 represents the maximum symptoms.

    Measured: Through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2025
  2. Study start19 Jun 2025 (estimated)
  3. Primary completion31 Jul 2025 (estimated)
  4. Study completion20 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case crossover
Time perspective
Cross-sectional
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07007923
Sponsor's protocol ID
No.HE-OT2023/13
Status last verified
May 2025
First submitted
10 May 2025
Last updated
6 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Diaphragm, run by Hong Kong Metropolitan University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yi On Mak, Bachelor of Physiotherapy (+85292328865, s1314212@live.hkmu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diaphragmatic thickening fraction (time frame: Through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in